Moreover, AD patients have a significant 50% higher plasma and serum cathepsin B protein level than age-matched control samples (120, 130) and higher serum cathepsin B levels in AD patients strongly correlates with reduced cognitive ability (120). Here, CTSB is linked to Alzheimer disease.